European Hearing Aids and Audiology Devices Market
The European hearing aids and audiology devices market shows that in 2012, 14.5% of the European population suffered from hearing impairment, which amounted to 59.6 million candidates who would benefit from using a hearing device.
Despite the high market potential for hearing aid devices, there is still a great deal of growth remaining in the European hearing aids and audiology devices market, as the penetration of hearing aid users in Europe is less than 20%. Growth of the hearing device market is largely dependent on the reimbursement policies of each country, the technological innovations that are offered by the manufacturers and the distribution of hearing aids by the retailers to the end users. The adoption rate of hearing aid users is expected to increase at a CAGR of 2%, leading to over 20% penetration by 2019.
Scope: The European Hearing Aids and Audiology Devices Market report pertains to a forecast period of 10 years (2009 – 2019) for Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K.
Report Contents:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “bottom up” approach, which includes primary and secondary research methods.
Despite the high market potential for hearing aid devices, there is still a great deal of growth remaining in the European hearing aids and audiology devices market, as the penetration of hearing aid users in Europe is less than 20%. Growth of the hearing device market is largely dependent on the reimbursement policies of each country, the technological innovations that are offered by the manufacturers and the distribution of hearing aids by the retailers to the end users. The adoption rate of hearing aid users is expected to increase at a CAGR of 2%, leading to over 20% penetration by 2019.
Scope: The European Hearing Aids and Audiology Devices Market report pertains to a forecast period of 10 years (2009 – 2019) for Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K.
Report Contents:
- Competitor Analysis
- Identified Strategic Opportunities
- Market Overview by Segment & Country
- Trend Analysis by Segment & Country
- Market Drivers & Limiters
- Mergers & Acquisitions
- Customer Feedback and Market Monitoring
- Hearing Aids
- Cochlear Implant
- Hearing Aid Battery
- Diagnostic Hearing Device
- Entendre
- Hans Anders
- Hansaton
- Amplifon
- AudioNova
- Hearing Company
- Hidden Hearing
- Ormerods/Boots
- Veranneman Appareils Auditifs
- Widex
- KIND Hörgerate
- Audika
- GAES
- Specsavers
- Maico
- Optical Chains
- Neuroth
- Lapperre BHAC
- Hartlauer
- Acustica Medica
- Audibel
- Audio 2000
- AudioNova
- Audition Conseil
- Audition Mutualiste
- Audition Sante
- Casa
- Sonotone
- Danish Hearing Aid Center
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “bottom up” approach, which includes primary and secondary research methods.
EXECUTIVE SUMMARY
1.1 INTERVENTIONAL CARDIOLOGY DEVICE MARKET
1.2 TREND ANALYSIS BY COUNTRY
1.3 PROCEDURE NUMBERS
1.4 CORONARY STENT MARKET
1.5 PTCA BALLOON MARKET
1.6 INTERVENTIONAL CORONARY CATHETER & GUIDEWIRE MARKET
1.7 CORONARY INTRODUCER SHEATH MARKET
1.8 CORONARY EMBOLIC PROTECTION DEVICE MARKET
1.9 CORONARY ATHERECTOMY DEVICE MARKET
1.10 DIAGNOSTIC CORONARY CATHETER & GUIDEWIRE MARKET
1.11 FRACTIONAL FLOW RESERVE GUIDEWIRE MARKET
1.12 CORONARY VASCULAR CLOSURE DEVICE MARKET
1.13 IVUS CATHETER MARKET
1.14 OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICE MARKET
1.15 VULNERABLE PLAQUE DEVICE MARKET
1.16 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKETS
3.1 INTRODUCTION
3.1.1 Population at Risk
3.2 CURRENCY EXCHANGE RATE
3.3 MARKET OVERVIEW
3.4 MARKET BY SEGMENT
3.4.1 Market Concentration
3.5 MARKET BY COUNTRY
3.5.1.1 Germany
3.5.1.2 France
3.5.1.3 United Kingdom
3.5.1.4 Italy
3.5.1.5 Spain
3.5.1.6 Benelux
3.5.1.7 Scandinavia
3.5.1.8 Portugal
3.5.1.9 Austria
3.5.1.10 Switzerland
3.6 TREND ANALYSIS BY COUNTRY
3.7 MARKET DRIVERS AND LIMITERS
3.7.1 Market Drivers
3.7.2 Market Limiters
3.8 COMPETITIVE ANALYSIS
3.9 MERGERS AND ACQUISITIONS
PROCEDURE NUMBERS
4.1 TOTAL PROCEDURE NUMBERS
4.2 GERMANY
4.3 FRANCE
4.4 UNITED KINGDOM
4.5 ITALY
4.6 SPAIN
4.7 BENELUX
4.8 SCANDINAVIA
4.9 PORTUGAL
4.10 AUSTRIA
4.11 SWITZERLAND
COUNTRY PROFILES
5.1 INTRODUCTION
5.1.1 Population
5.1.2 GDP Per Capita
5.1.3 PCI and DES Penetration Rates
5.1.4 Price Index
5.2 GERMANY
5.3 FRANCE
5.4 UNITED KINGDOM
5.5 ITALY
5.6 SPAIN
5.7 BENELUX
5.8 SCANDINAVIA
5.9 PORTUGAL
5.10 AUSTRIA
5.11 SWITZERLAND
CORONARY STENT MARKET
6.1 INTRODUCTION
6.2 MARKET OVERVIEW
6.3 MARKET ANALYSIS AND FORECAST
6.3.1 Total Coronary Stent Market
6.3.2 Total Coronary Stent Units Sold by Stent Diameter
6.3.3 Total Coronary Stent Units Sold by Stent Length
6.3.4 Drug-Eluting Stent Market
6.3.5 Bare-Metal Stent Market
6.4 MARKET DRIVERS AND LIMITERS
6.4.1 Drug-Eluting Stent Market
6.4.1.1 Market Drivers
6.4.1.2 Market Limiters
6.4.2 Bare-Metal Stent Market
6.4.2.1 Market Drivers
6.4.2.2 Market Limiters
6.5 COMPETITIVE ANALYSIS
6.5.1 Brands by Leading Competitors
6.5.2 Emerging Competitors
6.6 EMERGING TECHNOLOGIES
6.6.1 Bioabsorbable Coronary Stents
6.6.2 Bifurcated Coronary Stents
PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY BALLOON CATHETER MARKET
7.1 INTRODUCTION
7.1.1 Balloon Types
7.1.2 Drug-Eluting Balloons
7.1.3 PTCA Balloons by Classification
7.2 MARKET ANALYSIS AND FORECAST
7.3 PROCEDURES
7.3.1 Units per Procedure
7.3.2 Units Sold by Indication
7.4 MARKET DRIVERS AND LIMITERS
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 COMPETITIVE ANALYSIS
7.5.1 Brands by Leading Competitors
INTERVENTIONAL CORONARY CATHETER MARKET
8.1 INTRODUCTION
8.1.1 Units per Procedure
8.2 MARKET ANALYSIS AND FORECAST
8.3 MARKET DRIVERS AND LIMITERS
8.3.1 Market Drivers
8.3.2 Market Limiters
8.4 COMPETITIVE ANALYSIS
8.4.1 Brands by Leading Competitors
INTERVENTIONAL CORONARY GUIDEWIRE MARKET
9.1 INTRODUCTION
9.1.1 Device Construction
9.1.2 Hydrophilic Guidewires
9.1.3 Units per Procedure
9.2 MARKET ANALYSIS AND FORECAST
9.3 MARKET DRIVERS AND LIMITERS
9.3.1 Market Drivers
9.3.2 Market Limiters
9.4 COMPETITIVE ANALYSIS
9.4.1 Brands by Leading Competitors
CORONARY INTRODUCER SHEATH MARKET
10.1 INTRODUCTION
10.1.1 The Femoral Approach
10.1.2 Radial/Brachial Approach
10.2 MARKET OVERVIEW
10.2.1 Units per Procedure
10.2.2 Coronary Introducer Sheath Market by Access Site
10.3 MARKET ANALYSIS AND FORECAST
10.3.1 Total Coronary Introducer Sheath Market
10.3.2 Standard Coronary Introducer Sheath Market
10.3.3 Coronary Micro-Introducer Sheath Market
10.4 MARKET DRIVERS AND LIMITERS
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 COMPETITIVE ANALYSIS
10.5.1 Brands by Leading Competitors
CORONARY EMBOLIC PROTECTION DEVICE MARKET
11.1 INTRODUCTION
11.1.1 Saphenous Vein Grafts
11.2 PROTECTION MECHANISM
11.3 MARKET ANALYSIS AND FORECAST
11.4 MARKET DRIVERS AND LIMITERS
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 COMPETITIVE ANALYSIS
11.5.1 Brands by Leading Competitors
CORONARY ATHERECTOMY DEVICE MARKET
12.1 INTRODUCTION
12.1.1 Atherectomy
12.1.2 Device Technologies
12.1.2.1 Mechanical Atherectomy
12.1.2.2 Laser Atherectomy
12.1.2.3 Directional Coronary Atherectomy (DCA)
12.2 MARKET ANALYSIS & FORECAST
12.3 MARKET DRIVERS AND LIMITERS
12.3.1 Market Drivers
12.3.2 Market Limiters
12.4 COMPETITIVE ANALYSIS
12.4.1 Brands by Leading Competitors
DIAGNOSTIC CORONARY CATHETER AND GUIDEWIRE MARKET
13.1 INTRODUCTION
13.2 MARKET OVERVIEW
13.3 MARKET ANALYSIS AND FORECAST
13.3.1 Total Diagnostic Coronary Catheter and Guidewire Market
13.4 DIAGNOSTIC CATHETER MARKET
13.5 DIAGNOSTIC GUIDEWIRE MARKET
13.6 MARKET DRIVERS AND LIMITERS
13.6.1 Market Drivers
13.6.2 Market Limiters
13.7 COMPETITIVE ANALYSIS
13.7.1 Brands by Leading Competitors
FRACTIONAL FLOW RESERVE GUIDEWIRE MARKET
14.1 INTRODUCTION
14.2 MARKET ANALYSIS AND FORECAST
14.3 MARKET DRIVERS AND LIMITERS
14.3.1 Market Drivers
14.3.2 Market Limiters
14.4 COMPETITIVE ANALYSIS
14.4.1 Brands by Leading Competitors
CORONARY VASCULAR CLOSURE DEVICE MARKET
15.1 INTRODUCTION
15.1.1 Invasive and Non-Invasive Devices
15.2 MARKET OVERVIEW
15.3 MARKET ANALYSIS AND FORECAST
15.3.1 Total Coronary VCD Market
15.3.2 Total Coronary VCD Market by Access Site
15.3.3 Invasive Coronary VCD Market
15.3.4 Non-Invasive Coronary VCD Market
15.4 MARKET DRIVERS AND LIMITERS
15.4.1 Market Drivers
15.4.2 Market Limiters
15.5 COMPETITIVE ANALYSIS
15.5.1 Brands by Leading Competitors
INTRAVASCULAR ULTRASOUND CATHETER MARKET
16.1 INTRODUCTION
16.1.1 Pre-Stenting Applications
16.1.2 Post-Stenting Applications
16.1.3 IVUS Console Penetration
16.2 MARKET ANALYSIS AND FORECAST
16.3 PENETRATION RATE
16.4 MARKET DRIVERS AND LIMITERS
16.4.1 Market Drivers
16.4.2 Market Limiters
16.5 COMPETITIVE ANALYSIS
16.5.1 Brands by Leading Competitors
OPTICAL COHERENCE TOMOGRAPHY CATHETER MARKET
17.1 INTRODUCTION
17.1.1 OCT Applications
17.2 MARKET ANALYSIS AND FORECAST
17.3 PENETRATION RATE
17.4 MARKET DRIVERS AND LIMITERS
17.4.1 Market Drivers
17.4.2 Market Limiters
17.5 COMPETITIVE ANALYSIS
17.5.1 Bramds by Leading Competitors
VULNERABLE PLAQUE DEVICE MARKET
18.1 INTRODUCTION
18.1.1 Vulnerable Plaque Screening Technologies
18.1.1.1 Intravascular Ultrasound (IVUS)
18.1.1.2 Optical Coherence Tomography (OCT)
18.1.1.3 Raman Spectroscopy
18.1.1.4 Near Infrared (NIR) Spectroscopy
18.1.1.5 Thermography
18.1.1.6 Intravascular Magnetic Resonance Imaging (IVMRI)
18.1.1.7 Computed Tomography (CT)
18.1.2 Potential Vulnerable Plaque Treatments
18.1.2.1 Stents
18.1.2.2 Pharmaceuticals
18.1.2.3 Photodynamic Therapies
18.1.2.4 Cryotherapy
18.2 TARGET POPULATION
18.3 MARKET ANALYSIS AND FORECAST
18.3.1 Total Potential Market
18.3.2 Potential Vulnerable Plaque Screening Market
18.3.3 Potential Vulnerable Plaque Treatment Market
18.4 MARKET DRIVERS AND LIMITERS
18.4.1 Market Drivers
18.4.2 Market Limiters
18.5 COMPETITIVE ANALYSIS
18.5.1 Past Companies and Technology
ABBREVIATIONS
1.1 INTERVENTIONAL CARDIOLOGY DEVICE MARKET
1.2 TREND ANALYSIS BY COUNTRY
1.3 PROCEDURE NUMBERS
1.4 CORONARY STENT MARKET
1.5 PTCA BALLOON MARKET
1.6 INTERVENTIONAL CORONARY CATHETER & GUIDEWIRE MARKET
1.7 CORONARY INTRODUCER SHEATH MARKET
1.8 CORONARY EMBOLIC PROTECTION DEVICE MARKET
1.9 CORONARY ATHERECTOMY DEVICE MARKET
1.10 DIAGNOSTIC CORONARY CATHETER & GUIDEWIRE MARKET
1.11 FRACTIONAL FLOW RESERVE GUIDEWIRE MARKET
1.12 CORONARY VASCULAR CLOSURE DEVICE MARKET
1.13 IVUS CATHETER MARKET
1.14 OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICE MARKET
1.15 VULNERABLE PLAQUE DEVICE MARKET
1.16 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKETS
3.1 INTRODUCTION
3.1.1 Population at Risk
3.2 CURRENCY EXCHANGE RATE
3.3 MARKET OVERVIEW
3.4 MARKET BY SEGMENT
3.4.1 Market Concentration
3.5 MARKET BY COUNTRY
3.5.1.1 Germany
3.5.1.2 France
3.5.1.3 United Kingdom
3.5.1.4 Italy
3.5.1.5 Spain
3.5.1.6 Benelux
3.5.1.7 Scandinavia
3.5.1.8 Portugal
3.5.1.9 Austria
3.5.1.10 Switzerland
3.6 TREND ANALYSIS BY COUNTRY
3.7 MARKET DRIVERS AND LIMITERS
3.7.1 Market Drivers
3.7.2 Market Limiters
3.8 COMPETITIVE ANALYSIS
3.9 MERGERS AND ACQUISITIONS
PROCEDURE NUMBERS
4.1 TOTAL PROCEDURE NUMBERS
4.2 GERMANY
4.3 FRANCE
4.4 UNITED KINGDOM
4.5 ITALY
4.6 SPAIN
4.7 BENELUX
4.8 SCANDINAVIA
4.9 PORTUGAL
4.10 AUSTRIA
4.11 SWITZERLAND
COUNTRY PROFILES
5.1 INTRODUCTION
5.1.1 Population
5.1.2 GDP Per Capita
5.1.3 PCI and DES Penetration Rates
5.1.4 Price Index
5.2 GERMANY
5.3 FRANCE
5.4 UNITED KINGDOM
5.5 ITALY
5.6 SPAIN
5.7 BENELUX
5.8 SCANDINAVIA
5.9 PORTUGAL
5.10 AUSTRIA
5.11 SWITZERLAND
CORONARY STENT MARKET
6.1 INTRODUCTION
6.2 MARKET OVERVIEW
6.3 MARKET ANALYSIS AND FORECAST
6.3.1 Total Coronary Stent Market
6.3.2 Total Coronary Stent Units Sold by Stent Diameter
6.3.3 Total Coronary Stent Units Sold by Stent Length
6.3.4 Drug-Eluting Stent Market
6.3.5 Bare-Metal Stent Market
6.4 MARKET DRIVERS AND LIMITERS
6.4.1 Drug-Eluting Stent Market
6.4.1.1 Market Drivers
6.4.1.2 Market Limiters
6.4.2 Bare-Metal Stent Market
6.4.2.1 Market Drivers
6.4.2.2 Market Limiters
6.5 COMPETITIVE ANALYSIS
6.5.1 Brands by Leading Competitors
6.5.2 Emerging Competitors
6.6 EMERGING TECHNOLOGIES
6.6.1 Bioabsorbable Coronary Stents
6.6.2 Bifurcated Coronary Stents
PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY BALLOON CATHETER MARKET
7.1 INTRODUCTION
7.1.1 Balloon Types
7.1.2 Drug-Eluting Balloons
7.1.3 PTCA Balloons by Classification
7.2 MARKET ANALYSIS AND FORECAST
7.3 PROCEDURES
7.3.1 Units per Procedure
7.3.2 Units Sold by Indication
7.4 MARKET DRIVERS AND LIMITERS
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 COMPETITIVE ANALYSIS
7.5.1 Brands by Leading Competitors
INTERVENTIONAL CORONARY CATHETER MARKET
8.1 INTRODUCTION
8.1.1 Units per Procedure
8.2 MARKET ANALYSIS AND FORECAST
8.3 MARKET DRIVERS AND LIMITERS
8.3.1 Market Drivers
8.3.2 Market Limiters
8.4 COMPETITIVE ANALYSIS
8.4.1 Brands by Leading Competitors
INTERVENTIONAL CORONARY GUIDEWIRE MARKET
9.1 INTRODUCTION
9.1.1 Device Construction
9.1.2 Hydrophilic Guidewires
9.1.3 Units per Procedure
9.2 MARKET ANALYSIS AND FORECAST
9.3 MARKET DRIVERS AND LIMITERS
9.3.1 Market Drivers
9.3.2 Market Limiters
9.4 COMPETITIVE ANALYSIS
9.4.1 Brands by Leading Competitors
CORONARY INTRODUCER SHEATH MARKET
10.1 INTRODUCTION
10.1.1 The Femoral Approach
10.1.2 Radial/Brachial Approach
10.2 MARKET OVERVIEW
10.2.1 Units per Procedure
10.2.2 Coronary Introducer Sheath Market by Access Site
10.3 MARKET ANALYSIS AND FORECAST
10.3.1 Total Coronary Introducer Sheath Market
10.3.2 Standard Coronary Introducer Sheath Market
10.3.3 Coronary Micro-Introducer Sheath Market
10.4 MARKET DRIVERS AND LIMITERS
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 COMPETITIVE ANALYSIS
10.5.1 Brands by Leading Competitors
CORONARY EMBOLIC PROTECTION DEVICE MARKET
11.1 INTRODUCTION
11.1.1 Saphenous Vein Grafts
11.2 PROTECTION MECHANISM
11.3 MARKET ANALYSIS AND FORECAST
11.4 MARKET DRIVERS AND LIMITERS
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 COMPETITIVE ANALYSIS
11.5.1 Brands by Leading Competitors
CORONARY ATHERECTOMY DEVICE MARKET
12.1 INTRODUCTION
12.1.1 Atherectomy
12.1.2 Device Technologies
12.1.2.1 Mechanical Atherectomy
12.1.2.2 Laser Atherectomy
12.1.2.3 Directional Coronary Atherectomy (DCA)
12.2 MARKET ANALYSIS & FORECAST
12.3 MARKET DRIVERS AND LIMITERS
12.3.1 Market Drivers
12.3.2 Market Limiters
12.4 COMPETITIVE ANALYSIS
12.4.1 Brands by Leading Competitors
DIAGNOSTIC CORONARY CATHETER AND GUIDEWIRE MARKET
13.1 INTRODUCTION
13.2 MARKET OVERVIEW
13.3 MARKET ANALYSIS AND FORECAST
13.3.1 Total Diagnostic Coronary Catheter and Guidewire Market
13.4 DIAGNOSTIC CATHETER MARKET
13.5 DIAGNOSTIC GUIDEWIRE MARKET
13.6 MARKET DRIVERS AND LIMITERS
13.6.1 Market Drivers
13.6.2 Market Limiters
13.7 COMPETITIVE ANALYSIS
13.7.1 Brands by Leading Competitors
FRACTIONAL FLOW RESERVE GUIDEWIRE MARKET
14.1 INTRODUCTION
14.2 MARKET ANALYSIS AND FORECAST
14.3 MARKET DRIVERS AND LIMITERS
14.3.1 Market Drivers
14.3.2 Market Limiters
14.4 COMPETITIVE ANALYSIS
14.4.1 Brands by Leading Competitors
CORONARY VASCULAR CLOSURE DEVICE MARKET
15.1 INTRODUCTION
15.1.1 Invasive and Non-Invasive Devices
15.2 MARKET OVERVIEW
15.3 MARKET ANALYSIS AND FORECAST
15.3.1 Total Coronary VCD Market
15.3.2 Total Coronary VCD Market by Access Site
15.3.3 Invasive Coronary VCD Market
15.3.4 Non-Invasive Coronary VCD Market
15.4 MARKET DRIVERS AND LIMITERS
15.4.1 Market Drivers
15.4.2 Market Limiters
15.5 COMPETITIVE ANALYSIS
15.5.1 Brands by Leading Competitors
INTRAVASCULAR ULTRASOUND CATHETER MARKET
16.1 INTRODUCTION
16.1.1 Pre-Stenting Applications
16.1.2 Post-Stenting Applications
16.1.3 IVUS Console Penetration
16.2 MARKET ANALYSIS AND FORECAST
16.3 PENETRATION RATE
16.4 MARKET DRIVERS AND LIMITERS
16.4.1 Market Drivers
16.4.2 Market Limiters
16.5 COMPETITIVE ANALYSIS
16.5.1 Brands by Leading Competitors
OPTICAL COHERENCE TOMOGRAPHY CATHETER MARKET
17.1 INTRODUCTION
17.1.1 OCT Applications
17.2 MARKET ANALYSIS AND FORECAST
17.3 PENETRATION RATE
17.4 MARKET DRIVERS AND LIMITERS
17.4.1 Market Drivers
17.4.2 Market Limiters
17.5 COMPETITIVE ANALYSIS
17.5.1 Bramds by Leading Competitors
VULNERABLE PLAQUE DEVICE MARKET
18.1 INTRODUCTION
18.1.1 Vulnerable Plaque Screening Technologies
18.1.1.1 Intravascular Ultrasound (IVUS)
18.1.1.2 Optical Coherence Tomography (OCT)
18.1.1.3 Raman Spectroscopy
18.1.1.4 Near Infrared (NIR) Spectroscopy
18.1.1.5 Thermography
18.1.1.6 Intravascular Magnetic Resonance Imaging (IVMRI)
18.1.1.7 Computed Tomography (CT)
18.1.2 Potential Vulnerable Plaque Treatments
18.1.2.1 Stents
18.1.2.2 Pharmaceuticals
18.1.2.3 Photodynamic Therapies
18.1.2.4 Cryotherapy
18.2 TARGET POPULATION
18.3 MARKET ANALYSIS AND FORECAST
18.3.1 Total Potential Market
18.3.2 Potential Vulnerable Plaque Screening Market
18.3.3 Potential Vulnerable Plaque Treatment Market
18.4 MARKET DRIVERS AND LIMITERS
18.4.1 Market Drivers
18.4.2 Market Limiters
18.5 COMPETITIVE ANALYSIS
18.5.1 Past Companies and Technology
ABBREVIATIONS
